We are live on
!
Find out more
PCM
Perkins Capital Management Portfolio holdings
AUM
$133M
1-Year Est. Return
127.86%
This Fund
S&P 500
This Quarter
Est. Return
+22.61%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$167M
AUM Growth
+$27M
(+19%)
Cap. Flow
+$12.7M
Cap. Flow
% of AUM
7.6%
Top 10 Holdings %
Top 10 Hldgs %
31.97%
Holding
144
New
17
Increased
44
Reduced
36
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VERO
Venus Concept
VERO
|
+$1.51M |
| 2 |
FPAY
FlexShopper
FPAY
|
+$1.49M |
| 3 |
IRIDEX
IRIX
|
+$1.16M |
| 4 |
Sensus Healthcare
SRTS
|
+$1.09M |
| 5 |
Natera
NTRA
|
+$940K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IVTY
Invuity, Inc
IVTY
|
+$1.22M |
| 2 |
Tactile Systems Technology
TCMD
|
+$1.09M |
| 3 |
FLXN
Flexion Therapeutics, Inc.
FLXN
|
+$1.08M |
| 4 |
Cibus
CBUS
|
+$833K |
| 5 |
OIG
Orbital Infrastructure Group, Inc. Common Stock
OIG
|
+$544K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 63.9% |
| 2 | Technology | 12.86% |
| 3 | Industrials | 6.55% |
| 4 | Communication Services | 4.39% |
| 5 | Consumer Discretionary | 4.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Axogen
AXGN
$2.77B
| $13.2M | 7.94% |
359,000
-6,675
| -2% | -$291K |
|
2
Vericel Corp
VCEL
$2.1B
| $7.78M | 4.67% |
549,750
-2,350
| -0.4% | -$27.6K |
|
3
CareDx
CDNA
$2.58B
| $6.09M | 3.66% |
211,060
+9,500
| +5% | +$178K |
|
4
Abbott
ABT
$195B
| $5.65M | 3.39% |
77,050
| – | – |
|
5
NeoGenomics
NEO
$2.32B
| $4.36M | 2.62% |
283,900
-5,900
| -2% | -$81.5K |
|
6
Idexx Laboratories
IDXX
$43.7B
| $3.33M | 2% |
13,350
| – | – |
|
|
7
Sensus Healthcare
SRTS
$57.9M
| $3.33M | 2% |
396,836
+149,950
| +61% | +$1.09M |
|
8
Apyx Medical
APYX
$130M
| $3.3M | 1.98% |
465,350
+64,650
| +16% | +$359K |
|
9
Champions Oncology
CSBR
$68.5M
| $3.15M | 1.89% |
180,600
+77,600
| +75% | +$691K |
|
|
TEUM
10
DELISTED
Pareteum Corporation
TEUM
| $3.03M | 1.82% |
1,008,729
+190,000
| +23% | +$512K |
|
11
Pfizer
PFE
$159B
| $2.98M | 1.79% |
71,218
+422
| +0.6% | +$16.2K |
|
12
OptimizeRx
OPRX
$150M
| $2.8M | 1.68% |
155,450
-1,668
| -1% | -$21K |
|
|
CSII
13
DELISTED
Cardiovascular Systems, Inc.
CSII
| $2.71M | 1.63% |
69,250
+900
| +1% | +$33.3K |
|
14
AtriCure
ATRC
$2.47B
| $2.67M | 1.6% |
76,250
+5,000
| +7% | +$158K |
|
15
Eli Lilly
LLY
$1.05T
| $2.53M | 1.52% |
23,610
| – | – |
|
16
LeMaitre Vascular
LMAT
$1.84B
| $2.5M | 1.5% |
64,400
-150
| -0.2% | -$5.41K |
|
|
17
Tactile Systems Technology
TCMD
$525M
| $2.45M | 1.47% |
34,505
-18,119
| -34% | -$1.09M |
|
18
Magnite
MGNI
$3.4B
| $2.45M | 1.47% |
680,500
+159,000
| +30% | +$562K |
|
19
BioLife Solutions
BLFS
$1.78B
| $2.44M | 1.46% |
139,150
-18,650
| -12% | -$369K |
|
20
Microsoft
MSFT
$3.81T
| $2.38M | 1.43% |
20,810
| – | – |
|
|
VRAY
21
DELISTED
ViewRay, Inc.
VRAY
| $2.22M | 1.33% |
237,550
+80,200
| +51% | +$788K |
|
|
TTSH
22
DELISTED
Tile Shop Holdings
TTSH
| $2.11M | 1.27% |
295,600
+40,600
| +16% | +$324K |
|
23
SPS Commerce
SPSC
$3.06B
| $2.08M | 1.25% |
41,900
+200
| +0.5% | +$8.96K |
|
24
Veracyte
VCYT
$3.48B
| $2.02M | 1.21% |
211,555
+60,700
| +40% | +$669K |
|
25
CryoPort
CYRX
$815M
| $2M | 1.2% |
156,400
-500
| -0.3% | -$7.14K |
|
Similar funds
AA
WA
AC
BCVI
SWM
HAP
RHIG
CWM
Perkins Capital Management's Q3 2018 Portfolio in Review
As of Q3 2018, Perkins Capital Management held 144 positions worth $167M, up 19% from $140M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Perkins Capital Management deployed $12.7M of net new capital in Q3 2018, opening 17 new positions and adding to 44 existing holdings. Its largest new stake was Venus Concept: 240 shares worth $1.73M.
By sector, the portfolio is most concentrated in Healthcare at 64% of assets, up from 62% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Tactile Systems Technology, an estimated $1.09M trimmed.
- Perkins Capital Management's largest Q3 2018 buy was Venus Concept: 240 shares worth $1.73M.
- Perkins Capital Management added most to IRIDEX in Q3 2018, an estimated $1.16M increase.
- Perkins Capital Management's biggest Q3 2018 reduction was Tactile Systems Technology, cutting an estimated $1.09M.
- Perkins Capital Management fully exited Invuity, Inc in Q3 2018, selling an estimated $1.22M.
- Perkins Capital Management's ten largest holdings make up 32% of its $167M portfolio in Q3 2018.
- Perkins Capital Management opened 17 new positions and closed 12 in Q3 2018.
- Perkins Capital Management's portfolio value rose 19% quarter-over-quarter to $167M.
Based on Perkins Capital Management's 13F filing for Q3 2018, filed 22 Oct 2018.